Physician profile
Evan Harrison
NPI 1053051953
$1,743.48
in general payments reported to CMS, 2019-2025
9 companies · $1,016 in 2025
The $1,016 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $122 · 2024: $605 · 2025: $1,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,643 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,643.49 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $589.94 | 2024-2025 | Clareon Panoptix Pro, Clareon, Hydrus Microstent |
| Amgen INC. | $245.23 | 2025 | Uplizna |
| Abbvie INC. | $224.99 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $204.44 | 2024-2025 | Ic-8 Apthera Iol, Envista Mx60 Iol |
| Sight Sciences, INC. | $136.91 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Sun Pharmaceutical Industries INC. | $124.80 | 2024 | |
| Rayner Intraocular Lenses Limited | $122.13 | 2023 | Omidria |
| New World Medical,INC. | $53.82 | 2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Glaukos Corporation | $41.22 | 2025 | Istent Inject W |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.